/Lists

Healthtech Series B Investors & VC Firms

1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.

Beaconsfield Capital
Seed–Series B
2 people
Cobalt Ventures
Kansas CitySeries A–Series B$10M – $75M
2 people
ExSight Ventures
New YorkPre-Seed–Series B
4 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
Empede Capital
TortolaSeed–Series B
4 people
Korify Capital
Series A–Series C
6 people
Ming capital
ShenzhenSeed–Series C
6 people
Ono Venture Investment, Inc.
South San FranciscoSeed–Series B
6 people
SBI JI Innovation Advisory Ltd.
Tel Aviv-YafoSeed–Series B
6 people
Oltre Impact
MilanSeries A–Growth$2.2M – $8.6M
8 people
Sirius Venture Partners GmbH
WiesbadenSeed–Growth$540K – $5.4M
8 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
BCF Ventures
MontrealSeed–Series B
7 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people
Seido Capital
BrusselsPre-Seed–Series B$270K – $2.7M
7 people
Split Rock Partners
Eden PrairieSeed–Growth$2M – $40M
4 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
BlueStone Venture Partners
TucsonSeed–Series B$250K – $1M
4 people
Iconica Partners
Silicon ValleySeed–Late Stage
4 people
Magnivia Ventures
New JerseyPre-Seed–Series B$250K – $750K
7 people
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Growth
3 people
Formation Group
Los AltosPre-Seed–Late Stage
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.